A Study of Crisaborole Ointment 2%; Crisaborole Vehicle; TCS and TCI in Subjects Aged ≥ 2 Years, With Mild-moderate AD
Clinical trial NCT03539601 · TERMINATED
Trial details
- NCT number
- NCT03539601
- Sponsor
- Pfizer
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-27
- Primary completion
- 2020-12-11
- Enrollment
- 237
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.